• Reuters
• 09 Apr, 2021

Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot Covid-19 vaccine in the country. The U.S. drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report.
Read more...